10-K: American Picture House narrows loss, ramps film slate

American Picture House Corporation’s 2025 10-K shows sharply higher revenue, a smaller net loss, new revenue waterfalls on released films, and fresh financing lines, but flags going concern risks and potential dilution.

Summary

• Business model: independent film co-financier/co-producer focusing on structured senior/priority recoupment positions and building owned/controlled IP; pivoted away from third‑party consulting in 2025.
• 2025 revenue rose to $853,017 (from $52,677 in 2024), largely from BARRON’S COVE-related receivables and fees; net loss narrowed to $534,440 (from $2,270,258).
• Accumulated deficit ~ $7.8 million at 12/31/2025; negative working capital of ~$435,000; cash and cash equivalents of $124 at year‑end.
• Accounts receivable of $1,150,000 at 12/31/2025 reflects APHP’s priority collection rights on BARRON’S COVE per the 12/29/2025 SSS amendment.
• Operating expenses fell: G&A $1,403,010 (from $2,252,130), driven by lower stock‑based compensation ($379k vs. $1.26m in 2024).
• Interest income $97,027 (mainly from Barron’s Cove loan); interest expense $70,898.
• Film slate and participation: BARRON’S COVE (released 6/6/2025), POSE (12/5/2025), THIEVES HIGHWAY (12/16/2025), PROTECTOR (U.S. theatrical 3/6/2026), MOTION (post‑production; targeted 2Q 2026).
• Key amendments/agreements with SSS Entertainment: 8/1/2025 agreement and 12/29/2025 amendment establishing APHP’s $1,150,000 first‑priority Net Revenues on BARRON’S COVE, then 85%/15% split to SSS/APHP until SSS recoupment, then 100% to APHP.
• Multi‑Film Investment & Compensation Agreement effective 1/27/2026 (board‑ratified 3/12/2026) covering POSE (fixed $575k payable due by 1/31/2027 after $175k partial), MOTION ($500k funding assigned economics), and an untitled SSS picture ($200k contemplated).
• Financing: Equity Line of Credit with RH2 Equity Partners up to the lesser of $100 million or the share cap (8/28/2025); Labrys Fund II promissory notes (9/22/2025: $115k; 1/20/2026: $172.5k incl. OID, convertible on default/missed amortization).
• Capital structure: 1,001,000,000 authorized (1,000,000,000 common; 1,000,000 preferred); 113,599,325 common shares outstanding as of 3/25/2026; CEO controls ~97.66% voting power via 3,839 Series A preferred.
• Going concern risk disclosed; company expects to continue incurring expenses and seeks capital through debt/equity financings, including equity‑linked instruments.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a mixed filing: sharply better revenue and defined waterfalls are positives, offset by going‑concern doubt, very low cash, dilution risk from the ELOC and convertible notes, and pending arbitration.

Positives

• Revenue increased to $853,017 (2025) from $52,677 (2024), reflecting ramp in project‑level receipts.
• Net loss narrowed to $534,440 from $2,270,258, aided by lower stock‑based compensation and reduced opex.
• Priority revenue waterfall on BARRON’S COVE secures first $1,150,000 of Net Revenues to APHP, with audit/reporting and quarterly disbursement mechanics.
• Multi‑film agreement (effective 1/27/2026) converts POSE payment structure to defined amounts with a due date of 1/31/2027 and secures assigned economics on MOTION.
• Improved visibility on receivables: $1,150,000 priority receivable recognized year‑end tied to executed waterfall.
• Equity line (up to $100M cap subject to share limits) and additional convertible note provide near‑term financing flexibility.

Negatives

• Cash of $124 at 12/31/2025 and negative working capital (~$435,000) underscore near‑term liquidity strain.
• Going concern substantial doubt disclosed; continued dependence on external financing.
• Convertible/variable‑price instruments (e.g., Labrys notes) and ELOC create dilution and potential downward price pressure.
• PNP Movie, LLC loan written off in full ($196,200), highlighting project default risk.
• Concentrated control: CEO beneficially controls ~97.66% voting power via Series A Preferred, limiting minority shareholder influence.

Risks

• Liquidity and capital access risk; inability to raise additional capital could force reductions or cessation of operations.
• Production, completion, and delivery risks may delay or reduce expected receipts from projects.
• Reliance on third‑party reporting, collection account managers, and distributors may lead to delayed/disputed/incomplete remittances.
• Convertible or equity‑linked financings may cause substantial dilution and stock price volatility.
• Foreign currency exposure and changing distribution models (streaming/AVOD) may affect monetization.
• Intellectual property enforcement and chain‑of‑title disputes could impair recoveries.
• Concentration of control in CEO and potential conflicts of interest.
• Pending arbitration (JAMS No. 5220010741; consolidated Jones matter) arising from consulting agreements; cannot estimate loss.
• Material weaknesses in internal controls and ineffective disclosure controls noted; remediation in progress.
• Negative operating capital and accumulated deficit (~$7.8 million) raise going concern doubt.

Future Outlook

Management plans to continue Phase 1 ‘execute and refine’ through Q2 2026, then scale selectively by acquiring/optioning IP and co‑financing projects subject to capital availability. Revenue is expected from contracted waterfalls (e.g., BARRON’S COVE), assigned economics on MOTION, and targeted Q2 2026 release for MOTION. Liquidity will rely on a mix of receivables, the RH2 ELOC, and opportunistic debt/equity financings, with ongoing focus on governance, auditability, and portfolio reporting.

Management Comments

• Pivoted away from third‑party consulting in 2025 to concentrate on internally developed projects and selective strategic partnerships.
• Emphasizes senior/priority recoupment structures and disciplined underwriting with defined waterfalls and UCC filings intended to reduce exposure relative to subordinated equity.
• Identified three operating phases: (1) execute and refine (through ~Q2 2026); (2) consolidate/integrate; (3) scale selectively beginning in 2026, subject to capital and market conditions.
• Acknowledges going‑concern uncertainty and the need to use borrowings and equity sales over the next 12 months to mitigate cash deficits.

Industry Context

StockSavvy.ai notes that independent film finance remains challenged by fragmented distribution economics, streaming-first release windows, and slower cash recoupment cycles. APHP’s use of collection account managers, first‑priority waterfalls, and UCC‑secured positions aligns with best practices seen among better‑structured indie financiers. However, compared to larger studios or well‑capitalized independents, access to capital and balance sheet depth remain key constraints driving reliance on equity‑linked financing, which carries dilution risk.

Comparison to Industry Standards

• Relative to larger independents (e.g., Lionsgate, Neon) with integrated distribution, APHP’s model leans on senior recoupment positions and CAM waterfalls, a common structure among boutique financiers but with higher counterparty/collection risk.
• Compared with peers employing slate finance backed by banks or mezzanine funds, APHP’s ELOC and small convertible notes provide flexibility but are costlier and more dilutive than bank-backed facilities.
• Studios or mini-majors typically avoid variable‑price convertibles due to perceived shareholder overhang; APHP’s use is consistent with early‑stage OTC micro‑caps rather than mature film companies.
• Utilization of CAMA and priority rights is aligned with industry best practices for independent productions seeking transparent, auditable revenue flows.

Management Changes

Corporate Governance

Legal Proceedings

• JAMS arbitration: Jonathan Sanger v. American Picture House Corporation (JAMS Case No. 5220010741), consolidated with Michael Jones matter; company disputes claims; cannot estimate loss.

Related Party Transactions

• Loans from CEO Bannor Michael MacGregor: $353,000 borrowed and $87,000 repaid in 2025 under master loan agreement at 4.4% interest.
• Loans from family trust related to CEO: $29,000 borrowed in 2025 (and $280,000 in 2024) at 4.4% interest.
• Legal fees paid to a firm affiliated with a former director: ~$105,000 (2025) and ~$180,000 (2024), with ~$145,000 payable at 12/31/2025.
• CEO controls 3,839 Series A preferred shares, each with 1,000,000 votes and 1:100,000 convertibility to common; overall ~97.66% voting control.
• January 27, 2026 assignment to SSS Entertainment of $350,000 of Company indebtedness owed to MacGregor and a family trust; Company to issue $350,000 in value of common shares to MacGregor/trust.
• Bold Crayon asset purchase (2022) and related Buffaloed receivable/participation; associated contingent preferred share issuances described.

Stakeholder Impact

• Shareholders: Significant potential dilution from the RH2 ELOC, Labrys convertible notes, stock‑based incentives, and Series A preferred convertibility; concentrated voting control may limit minority influence.
• Creditors: Priority waterfalls and UCC security interests can protect recoveries at project level but company‑level liquidity remains tight.
• Employees/Consultants: Equity plan expansion provides incentives but relies on share issuance capacity; company has no employees as of 12/31/2025.
• Production partners: Clearer CAM/reporting obligations and defined waterfalls improve transparency but require strict adherence to delivery and collection protocols.

Next Steps

• Pursue collections under BARRON’S COVE waterfall until APHP’s $1,150,000 priority is satisfied and thereafter per the amended split.
• Fund and secure assigned economics on MOTION per the EFA, finalize CAMA direct‑pay mechanics, and begin receipts post‑release.
• Manage POSE obligations: $175,000 partial already paid; $575,000 due on or before January 31, 2027.
• Engage RH2 ELOC and other facilities selectively to bridge liquidity and scale slate, while addressing control deficiencies and improving disclosure controls.

Key Dates

Recommendation

Revenue growth and defined first‑priority revenue rights on BARRON’S COVE are constructive and the multi‑film framework can compound returns if collections track. However, going concern uncertainty, low cash, reliance on convertible/equity facilities, pending arbitration, and control/dilution risks argue for a cautious stance until execution translates into sustained cash receipts and improved balance sheet metrics.

Keywords

independent film finance, revenue waterfall, collection account management, convertible note, equity line of credit, BARRON’S COVE, POSE, THIEVES HIGHWAY, PROTECTOR, MOTION, SSS Entertainment, Labrys Fund, RH2 Equity Partners, Series A Preferred, going concern